Earlier this week, the NHS also began offering booster jab appointments for vulnerable groups
Earlier this week, the NHS also began offering booster jab appointments for vulnerable groups
Company will also begin recruiting adolescents into Phase III vaccine trial
Under the partnership, AZ will support VaxEquity with research and development funding
Agreement will evaluate Verastem’s dual RAF/MEK inhibitor with Amgen’s KRAS G12C inhibitor
Positive opinions recommend approval for mAb in three additional eosinophil-driven diseases
Cancer Research UK has partnered with the University of Edinburgh’s ‘venture builder incubator’
Review sets out practical and cultural changes to ensure patients get the most appropriate treatments
Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19
Cabometyx found to reduce the risk of disease progression or death versus placebo in this patient population
Adagrasib is an investigational oral small-molecule inhibitor of KRAS G12C
Results showed vaccine has favourable safety profile in this age group
‘Groundbreaking results’ for the treatment of HER2-positive metastatic breast cancer
Drug combination could offer a new option for treatment-resistant advanced ovarian cancer
Positive data presented at the 2021 ESMO virtual congress
Leading the agency side, Havas Life Medicom came out on top with three Gold award wins